Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
It's one molecule in a large system, and individual results vary and depend on a clinical evaluation
N.FangW.ZhangD.et al
Modifications of position 12 in a parathyroid hormone and parathyroid hormone-related protein: toward the design of highly potent antagonists
Mechanistic Understanding Gaps Fundamental aspects of PT-141s mechanism remain incompletely characterized: Precise molecular pathways linking MC4R activation to behavioral changes undefined Relative contributions of different melanocortin receptor subtypes unclear Role of downstream neurotransmitter systems (dopamine, norepinephrine, serotonin) incompletely mapped Why effects on sexual desire persist beyond drug elimination half-life remains unexplained Individual variation in response not well predicted by current biomarkers Long-Term Safety and Efficacy Data Critical safety questions remain inadequately addressed: Chronic use effects beyond one year unstudied in controlled trials Long-term cardiovascular safety requires extended monitoring given transient blood pressure effects Persistent hyperpigmentation risk with frequent use not fully characterized Developmental and reproductive toxicity data limited Effects on fertility and pregnancy outcomes require further study The longest controlled trial duration was 52 weeks, leaving questions about multi-year safety unanswered
Epub 2010 Oct 28
US$ 21.21
US$ 26.05
US$ 25.91
US$ 22.06
US$ 28.02
US$ 25.25
US$ 24.75
US$ 25.21
US$ 27.20
